Steris | STE - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
3M USD 744M 221M 2026-03
Accuray USD 124.78M 2.54M 2025-12
Avanos Medical USD 77.7M 1.1M 2026-03
Baxter International USD 728M 33M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Boston Scientific USD 1.78B 53M 2026-03
CONMED USD 141.7M 25.06M 2026-03
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 349.7M 49.8M 2026-03
Ecolab USD 1.1B 41.4M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Fortive USD 417.3M 100K 2026-03
Getinge SEK 2.65B 452M 2024-12
Globus Medical USD 297.77M 20.7M 2026-03
Haemonetics USD 109.15M 7.54M 2025-12
Idexx Laboratories USD 299.85M 24.18M 2026-03
Inogen USD 43.77M 510K 2024-06
Insulet USD 317.2M 14.2M 2026-03
Integra LifeSciences USD 178.24M 21.79M 2026-03
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Olympus JPY 139.34B 13.69B 2026-03
Orthofix International USD 130.35M 11.31M 2025-12
Owens Minor USD 258.98M 7.5M 2025-12
ResMed USD 279.8M 1.4M 2026-03
Steris USD 351.8M 500K 2026-03
Stryker USD 2.15B 17M 2026-03
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 226.01M 3.64M 2026-03
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Zimmer Biomet Holdings USD 849.9M 5.8M 2026-03